Stereotactic radiotherapy (SRT) for oligometastatic (OM) relapse and metastatic oligoprogression (OP) in renal cell carcinoma (RCC) patients (pts): A study of the GETUG group.
2016 ◽
Vol 34
(15_suppl)
◽
pp. e16105-e16105
◽
2016 ◽
Vol 118
(3)
◽
pp. 540-546
◽
2018 ◽
Vol 127
(3)
◽
pp. 501-506
◽
Keyword(s):
2012 ◽
Vol 110
(11b)
◽
pp. E737-E743
◽
Keyword(s):